3 completed, 1 terminated, 1 withdrawn. 2 Not applicable, 2 Phase 4, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 4 | 2 | Terminated 1, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
Follow beta-Fructofuranosidase: new trials by email Literature Review of beta-Fructofuranosidase trials Research Report on beta-Fructofuranosidase
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effects of Oral Fructanase Administration on Gastrointestinal Symptoms After Inulin Challenge in Healthy Adults Fructanase, Maltodextrin placebo - Digestive Health, Gastrointestinal Health | Not applicable | Completed | BIO-CAT, Inc. | 30 | 2024-11-04 | 2026-09-30 |
| Effects of Sacrosidase and Placebo in Subjects With Fructan Intolerance Sacrosidase Oral Solution, Placebo - Fructan Intolerance | Phase 2 | Completed | QOL Medical, LLC | 25 | 2023-06-05 | 2026-06-30 |
| Safety and Tolerability Trial of Microbial Inulinase Inulinase, Maltodextrin placebo - Digestive Health, Gastrointestinal Health | Not applicable | Completed | BIO-CAT, Inc. | 60 | 2023-04-28 | 2024-09-27 |
| 7-Day Trial of Sucraid for Alleviating CSID Symptoms in Subjects With Low, Moderate, and Normal Sucrase Levels Sucraid (sacrosidase) Oral Solution 8500 IU/mL - Congenital Sucrase-Isomaltase Deficiency, CSID | Phase 4 | Terminated | QOL Medical, LLC | 312 | 2022-08-01 | 2025-03-20 |
| A Trial to Evaluate the Frequency of Genetic Sucrase-Isomaltase Deficiency Genotypes, and the Efficacy and Safety of Sucraid® (Sacrosidase) Oral Solution in Subjects With Chronic Diarrhea and Sucrase Deficiency Sucraid, Placebo - Genetic Sucrase-Isomaltase Deficiency | Phase 4 | Withdrawn | QOL Medical, LLC | 2016-05-01 | 2017-09-25 |
Flatulence (1) · Food Intolerance (1) · Sucrase-isomaltase deficiency, congenital (1)
QOL Medical, LLC (3) · BIO-CAT, Inc. (2)
United States (3) · Canada (1)
Weng Tao, M.D., Ph. D (2) · Aditi M. Shaw, MD (1) · Anthony Bier, MD, CCFP (1)